James R. Mault, M.D., F.A.C.S., Senior VP and Chief Medical Officer

James R. Mault, M.D., F.A.C.S., Senior VP and Chief Medical Officer

James Mault, MD, FACS, is the Senior Vice President and Chief Medical Officer of Qualcomm Life. His leadership responsibilities include Strategic Planning and Business Development, M&A, New Product Innovation and R&D, Clinical/Regulatory Oversight, Health Policy, Government Affairs and External Affairs. Dr Mault came to Qualcomm Life through its 2013 acquisition of HealthyCircles, a Care Coordination RPM Platform Company founded and led by Dr. Mault in 2009. Prior to starting HealthyCircles, he was the Director of New Products, Business Development and Clinical Programs for the Health Solutions Group at Microsoft. Dr. Mault has more than 35 years of experience in senior executive positions in the Health IT / Med-Tech industry as well as clinical medicine. Dr. Mault has founded five Health IT and medical device companies, raising over $100 million in working capital and leading these companies to develop novel devices and software technologies, FDA approvals, and strategic partnerships with Fortune 500 companies, culminating in M&A and IPO exits. He is the inventor of over 80 Patents for a variety of novel health information and medical device innovations. He has been board-certified in General Surgery and Cardiothoracic Surgery, having specialized in heart/lung transplantation, thoracic oncology and critical care. He conducted medical research under grant awards from the NIH, American Cancer Society, etc., and is the author of more than 60 scientific articles, chapters and books in the published medical literature. Dr. Mault received his Bachelors and Medical Degrees from the Univ of Michigan, and completed General and Cardiothoracic Surgery residencies at Duke Univ Medical Center. Dr. Mault provides global thought-leadership on various Boards including the Consumer Technology Association’s (CTA) Executive Board and Chair of the CTA Health & Fitness Technology Board, the ATA, AdvaMed, NSF Nano-systems Engineering Research, and the WEF Healthcare Working Group.